Hexadecanoic Acid Allyl Ester

Hexadecanoic Acid Allyl Ester

SCHEMBL370895

C=CCOC(=O)CCCCCCCCCCCCCCC

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 1.00
DGKA P23743 2/20 0.62
PAM P19021 2/20 0.56
LMNA P02545 5/20 0.53
MAPT P10636 1/20 0.53
ALDH1A1 P00352 2/20 0.51
DNM1 Q05193 1/20 0.51
KDM4E B2RXH2 1/20 0.50
DUSP3 P51452 1/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
FAAH O00519 1/20 0.49
PRKCA P17252 1/20 0.47
PRKCE Q02156 1/20 0.47
PRKCQ Q04759 1/20 0.47
PRKCD Q05655 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL435885 1.00 TSHR (1.00) TSHRDGKAPAMLMNAMAPT
Allyl Decanoate SCHEMBL436741 1.00 TSHR (1.00) TSHRDGKAPAMLMNAMAPT
SCHEMBL439396 1.00 TSHR (1.00) TSHRDGKAPAMLMNAMAPT
SCHEMBL3503097 1.00 TSHR (1.00) TSHRDGKAPAMLMNAMAPT
Allyl Octanoate SCHEMBL126629 1.00 TSHR (1.00) TSHRDGKAPAMLMNAMAPT
Allyl Heptanoate SCHEMBL4147097 1.00 TSHR (1.00) TSHRDGKAPAMLMNAMAPT
Allyl Heptanoate SCHEMBL20820 1.00 TSHR (1.00) TSHRDGKAPAMLMNAMAPT
SCHEMBL440501 1.00 TSHR (1.00) TSHRDGKAPAMLMNAMAPT
SCHEMBL19133353 1.00 TSHR (1.00) TSHRDGKAPAMLMNAMAPT
SCHEMBL1176823 1.00 TSHR (1.00) TSHRDGKAPAMLMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1555 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118714857-A Heat flow regulating photoelectric device and preparation method thereof 兰州理工大学 2024-09-27 CN claimed
CN-118043029-A Foaming composition 莱雅公司 2024-05-14 CN claimed
WO-2024091162-A1 UV FILTER COMPOSITION COMPRISING TRITERPENES, EMOLLIENTS AND INORGANIC UV-FILTERS AAK AB (PUBL) (SE) 2024-05-02 WO claimed
US-20240108558-A1 COMPOSITION FOR CARING FOR THE SKIN L'OREAL (FR) 2024-04-04 US claimed
WO-2024037784-A1 COSMETIC COMPOSITION COMPRISING ANIONIC AND/OR AMPHOTERIC SURFACTANTS, AT LEAST TWO DIFFERENT CATIONIC POLYSACCHARIDES AND ONE OR MORE SILICONES L'OREAL (FR) 2024-02-22 WO claimed
EP-3458018-B2 COSMETIC COMPOSITION COMPRISING ANIONIC SURFACTANTS, AMPHOTERIC SURFACTANTS, CATIONIC POLYMERS AND LIQUID FATTY SUBSTANCES CHOSEN FROM FATTY ALCO-HOLS AND FATTY ESTERS, AND COSMETIC TREATMENT PROCESS OREAL (FR) 2024-02-07 EP claimed
EP-4301316-A1 TWO-PHASE COMPOSITION L'OREAL (FR) 2024-01-10 EP claimed
CN-117209367-A Fluorenyl bisphenol monomer and fluorenyl polyarylether resin, and preparation method and application thereof 大连理工大学 2023-12-12 CN claimed
CN-117015365-A two-phase composition 莱雅公司 2023-11-07 CN claimed
EP-4262687-A1 COMPOSITION FOR CARING FOR THE SKIN L'OREAL (FR) 2023-10-25 EP claimed
EP-0976384-B1 Cosmetic and/or dermatological biphasic composition for eyes make-up removal OREAL (FR) 2001-07-25 EP claimed
US-6238680-B1 OIL IN WATER EMULSION CONTAINING AMMONIUM BROMIDE L'OREAL (FR) 2001-05-29 US claimed
WO-2000044287-A1 CYANOACRYLATES COMPRISING INHIBITORS AND AN OPACIFYING AGENT AS ADHESIVES PROHOLD MEDICAL TECHNOLOGIES, INC. (US) 2000-08-03 WO claimed
EP-0827736-B1 Use of biphasic composition for the make-up removal of non-transfer make-up compositions OREAL (FR) 2000-01-12 EP claimed
EP-0603080-B1 Cosmetic or dermatologic two-phase composition for make-up removal, skin cleaning or skin care containing an alkyldimethylbenzylammonium chloride OREAL (FR) 1996-07-10 EP claimed
US-5468496-A Containing an alkyldimethylbenzylammonium chloride as demixing agent in aqueous or oily phase and surfactants L'OREAL (FR) 1995-11-21 US claimed
US-5456852-A Microcapsule containing compound capable of undergoing phase transitions and high melting compound; preventing supercooling MITSUBISHI PAPER MILLS LIMITED (JP) 1995-10-10 US claimed
EP-0370856-B2 Eye make-up remover with two distinct phases OREAL (FR) 1995-08-30 EP claimed
US-5165917-A Water phase with a surfactant and an oily phase of cosmetic oil SOCIETE ANONYME DITE: L'OREAL (FR) 1992-11-24 US claimed
US-4396706-A ADDITION INTERPOLYMER PARTICLES, MATTES FUJI PHOTO FILM CO., LTD. (JP) 1983-08-02 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240108558-A1 COMPOSITION FOR CARING FOR THE SKIN CPT2, SPTLC2, CPT1B TSHR 3463/4885DGKA 1909/4885PAM 4826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.